• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Walgreens Boots Alliance Names Lanesha Minnix Executive Vice President and Global Chief Legal Officer

    2/26/24 4:05:00 PM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $WBA alert in real time by email

    Appointment completes CEO Tim Wentworth's Executive Committee

    Walgreens Boots Alliance, Inc. (NASDAQ:WBA) today named Lanesha Minnix the company's executive vice president (EVP) and global chief legal officer. Minnix, most recently EVP, general counsel and corporate secretary for Ecolab, Inc., will assume her new role with WBA on April 15.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240226589815/en/

    Lanesha Minnix named global chief legal officer, Walgreens Boots Alliance (Photo: Business Wire)

    Lanesha Minnix named global chief legal officer, Walgreens Boots Alliance (Photo: Business Wire)

    Minnix, who will report to WBA CEO Tim Wentworth and serve on his Executive Committee, will oversee the company's global legal, compliance, corporate governance and corporate security functions.

    "Lanesha is a widely respected leader and legal expert, and we are thrilled to welcome her to WBA in this important role," said Wentworth. "The healthcare and retail landscapes continue to evolve, and her legal guidance and expertise will be invaluable as we continue to expand our reach beyond neighborhood pharmacies into other fast-growing areas of healthcare."

    "I am excited and inspired by the unique opportunity to join WBA, and its trusted and iconic brands that meet the pharmacy and healthcare needs of thousands of communities every day," Minnix said. "I look forward to working with Tim and the Executive Committee, as well as other leaders across the global legal function and the organization more broadly, to advance WBA's business objectives, deliver sustainable value for stakeholders and position the company for long-term success."

    Prior to joining Ecolab, Minnix served as senior vice president and chief legal officer for Flowserve, leading the company's legal, compliance and regulatory teams. Previously, she served as senior vice president and general counsel for BMC Stock Holdings. Earlier in her career, Minnix held roles with increasing responsibility at ABM Industries, Shell Oil Company and Sprint. She began her career as a corporate associate at the law firm of K&L Gates. Read her full bio here.

    Minnix is a member of the Executive Leadership Council (ELC) and holds a juris doctor and an MBA from the University of Tulsa, as well as a bachelor's degree in marketing from St. Louis University.

    Her appointment follows several key leadership announcements for WBA and completes Wentworth's Executive Committee. Earlier this month, the company announced the appointment of Manmohan Mahajan as EVP and global chief financial officer, Elizabeth Burger as EVP and chief human resources officer and Mary Langowski as EVP and president, U.S. Healthcare.

    About Walgreens Boots Alliance

    Walgreens Boots Alliance (NASDAQ:WBA) is an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, with a 170-year heritage of caring for communities. A trusted, global innovator in retail pharmacy with approximately 12,500 locations across the U.S., Europe and Latin America, WBA plays a critical role in the healthcare ecosystem. The Company is reimagining local healthcare and well-being for all as part of its purpose – to create more joyful lives through better health. Through dispensing medicines, improving access to a wide range of health services, providing high quality health and beauty products and offering anytime, anywhere convenience across its digital platforms, WBA is shaping the future of healthcare.

    WBA employs more than 330,000 people and has a presence in eight countries through its portfolio of consumer brands: Walgreens, Boots, Duane Reade, the No7 Beauty Company and Benavides in Mexico. Additionally, WBA has a portfolio of healthcare-focused investments located in several countries, including China and the U.S.

    The Company is proud of its contributions to healthy communities, a healthy planet, an inclusive workplace and a sustainable marketplace. WBA has been recognized for its commitment to operating sustainably: the Company is an index component of the Dow Jones Sustainability Indices (DJSI) and was named to the 100 Best Corporate Citizens 2022.

    More Company information is available at www.walgreensbootsalliance.com.

    (WBA-GEN)

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240226589815/en/

    Get the next $WBA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $WBA

    DatePrice TargetRatingAnalyst
    2/28/2025$11.00 → $9.00Hold → Sell
    Deutsche Bank
    2/26/2024$23.00Market Perform
    Leerink Partners
    2/20/2024Hold → Reduce
    HSBC Securities
    1/3/2024$21.00Underweight
    Barclays
    12/22/2023$27.00Hold
    HSBC Securities
    10/23/2023$27.00 → $30.00Neutral → Overweight
    JP Morgan
    7/3/2023$37.00 → $27.00Underweight
    Morgan Stanley
    6/28/2023$46.00 → $34.00Buy → Hold
    Deutsche Bank
    More analyst ratings